Differential pattern of brain-specific CSF proteins tau and amyloid-beta in Parkinsonian syndromes-Reference-Cited by-同舟云学术

Differential pattern of brain-specific CSF proteins tau and amyloid-beta in Parkinsonian syndromes

Published:2010-06-29 Issue:9 Volume:25 Page:1284-1288
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Süssmuth Sigurd D.,Uttner Ingo,Landwehrmeyer Bernhard,Pinkhardt Elmar H.,Brettschneider Johannes,Petzold Axel,Kramer Bernd,Schulz Jörg B.,Palm Christian,Otto Markus,Ludolph Albert C.,Kassubek Jan,Tumani Hayrettin

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference33 articles.

1. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases;Hughes;J Neurol Neurosurg Psychiatry,1992

2. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service;Hughes;Brain,2002

3. Recent advances in atypical parkinsonian disorders;Litvan;Curr Opin Neurol,1999

4. Accuracy of clinical diagnosis of progressive supranuclear palsy;Osaki;Mov Disord,2004

5. Accuracy of clinical diagnosis in parkinsonism--a prospective study;Rajput;Can J Neurol Sci,1991

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA);Journal of Neurology;2024-09-10

2. Diagnostic Biomarkers of Parkinson's Disease;Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease;2023-08-04

3. Head-to-head comparison of 6 plasma biomarkers in early multiple system atrophy;npj Parkinson's Disease;2023-03-15

4. Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson’s Disease;Advances in Neurobiology;2023

5. The Role of Tau beyond Alzheimer’s Disease: A Narrative Review;Biomedicines;2022-03-24